COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,254 Articles (22,733 medRxiv, 8,521 bioRxiv)

Most recent first Previous |  Page 1097: Articles 10961-10970  | Next

Comparing human and model-based forecasts of COVID-19 in Germany and Poland
Bosse, N. I., Abbott, S., Bracher, J., Hain, H., Quilty, B. J., Jit, M., Centre for the Mathematical Modelling of Infectious Diseases COVID-19 Working Group, , van Leeuwen, E., Cori, A., Funk, S.
10.1101/2021.12.01.21266598 — Posted: 2021-12-05
The reactogenicity and immunogenicity of a booster dose after the second dose of a protein subunit vaccine MVC-COV1901.
Hsieh, S.-M., Chang, S.-c., Cheng, H.-Y., Shih, S.-R., Lien, C. E.
10.1101/2021.12.01.21267115 — Posted: 2021-12-05
Price-performance comparison of HEPA air purifiers and lower-cost MERV 13/14 filters with box fans for filtering out SARS-Cov-2 and other particulate aerosols in indoor community settings
Srikrishna, D.
10.1101/2021.12.04.21267300 — Posted: 2021-12-05
The Impact of COVID-19 on NO2 and PM2.5 Levels and Their Associations with Human Mobility Patterns in Singapore
Li, Y., Zhu, Y., Tan, J. Y. K., Teo, H. C., Law, A., Qu, D., Luo, W.
10.1101/2021.12.02.21267165 — Posted: 2021-12-05
Mental sequelae of the Covid-19 pandemic: Well-being one year into the crisis in children with and without complex medical histories and their parents
Ehrler, M., Hagmann, C. F., Kretschmar, O., Landolt, M. A., Latal, B., Wehrle, F. M.
10.1101/2021.12.05.21267236 — Posted: 2021-12-05
High viral loads: what drives fatal cases of COVID-19 in vaccinees? an autopsy study
Hirschbuehl, K., Schaller, T., Maerkl, B., Claus, R., Sipos, E., Rentschler, L., Maccagno, A., Grosser, B., Kling, E., Neidig, M., Kroencke, T., Spring, O., Braun, G., Boesmueller, H., Seidl, M., Esposito, I., Pablik, J., Hilsenbeck, J., Boor, P., Beer, M., Dintner, S., Wylezich, C.
10.1101/2021.12.03.21267155 — Posted: 2021-12-04
Single immunization with recombinant ACAM2000 vaccinia viruses expressing the spike and the nucleocapsid proteins protect hamsters against SARS-CoV-2 caused clinical disease
Cao, J., Deschambault, Y., Lynch, J., Warner, B., Tierney, K., Huynh, D., Vendramelli, R., Tailor, N., Booth, S., Sajesh, B., Frost, K., LeBlanc, K., Layne, C., Lin, L., Beniac, D., Carpenter, M., Safronetz, D., Li, X., Kobasa, D.
10.1101/2021.12.02.470987 — Posted: 2021-12-03
PEPPI: Whole-proteome protein-protein interaction prediction through structure and sequence similarity, functional association, and machine learning
Bell, E. W., Schwartz, J. H., Freddolino, P. L., Zhang, Y.
10.1101/2021.12.02.470917 — Posted: 2021-12-03
Post-Translational Modifications Optimize the Ability of SARS-CoV-2 Spike for Effective Interaction with Host Cell Receptors
Kapoor, K., Chen, T., Tajkhorshid, E.
10.1101/2021.12.02.470852 — Posted: 2021-12-03
Omicron and Delta Variant of SARS-CoV-2: A Comparative Computational Study of Spike protein
Kumar, S., Thambiraja, T. S., Karuppanan, K., Subramaniam, G.
10.1101/2021.12.02.470946 — Posted: 2021-12-03 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).